Long-Term Dialysis Is a Renal Tx Risk by ProQuest

VIEWS: 2 PAGES: 2

A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.

More Info
									HD_Tx1108    1/5/09     11:51 AM      Page 3




      www.renalandurologynews.com                                                                                   DECEMBER 2008          Renal & Urology News 23




       Long-Term Dialysis Is a Renal Tx Risk
       Pretransplant hemodialysis over 10 years found to predict worse graft and patient survival
      PATIENTS ON hemodialysis (HD)                  89.2% and 95.8%, respectively, at one   and 93.1%, respectively. Eight patients   virus and cytomegalovirus infection,
      for more than 10 years prior to renal          year, 60.4% and 88.5% at five years,    in the long-term group (20.5%) experi-    were more frequent in the long-term
      transplantation have worse outcomes            and 33.4% and 80.4% at 10 years, the    enced acute rejection compared with       group. The researchers believe impaired
      after receiving their kidneys com-             authors reported in Transplantation     63 in the short-term group (15.7%).       intestinal absorption reduced uptake of
      pared with patients who received HD            Proceedings (2008;40:2297-2298). Pa-      Pretransplant complications, includ-    immunosuppressive agents, which led
      for shorter periods.                           tient survival rates were 93.2% and     ing diabetes mellitus, cardiovascular     to deficits in immunosuppression and
        This study of 436 patients who under-        98.6%, 79.3% and 95.4%, and 58.4%       disease, hypertension, and hepatitis C    subsequent acute rejection episodes. I
      went renal transplantation was led by
      Hidetaka Ushigome, MD, PhD, and
      his team at Kyoto Prefectural University
      Graduate School of Medical Science.
      Of this cohort, 39 patients had been
      treated
								
To top